NeurAxis to Participate in the Lytham Partners Fall 2024 Investor Conference on October 1, 2024
19 September 2024 - 3:00PM
NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American:
NRXS), a medical technology company commercializing neuromodulation
therapies addressing chronic and debilitating conditions in
children and adults, will participate in a webcasted presentation
and host one-on-one meetings with investors at the Lytham Partners
Fall 2024 Investor Conference, taking place virtually on Tuesday,
October 1, 2024.
Company Webcast
The webcasted presentation will take place at 12:30 p.m. ET on
Tuesday, October 1, 2024. The webcast can be accessed by visiting
the conference home page at https://lythampartners.com/fall2024 or
directly at https://app.webinar.net/jvobBr8X2qa. The webcast will
also be available for replay following the event.
1×1 Meetings
Management will be participating in virtual one-on-one meetings
throughout the event. To arrange a meeting with management, please
contact Lytham Partners at 1×1@lythampartners.com or register for
the event at https://lythampartners.com/fall2024invreg.
About NeurAxis, Inc.
NeurAxis, Inc., is a medical technology company focused on
neuromodulation therapies to address chronic and debilitating
conditions in children and adults. NeurAxis is dedicated to
advancing science and leveraging evidence-based medicine to drive
adoption of its IB-Stim™ therapy, which is its proprietary
Percutaneous Electrical Nerve Field Stimulation (PENFS) technology,
by the medical, scientific, and patient communities. IB-Stim™ is
FDA cleared for functional abdominal pain associated with irritable
bowel syndrome (IBS) in adolescents 11-18 years old. Additional
clinical trials of PENFS in multiple pediatric and adult conditions
with large unmet healthcare needs are underway. For more
information, please visit http://neuraxis.com.
Contacts
CompanyNeurAxis,
Inc.info@neuraxis.com
Investor RelationsLytham PartnersBen
Shamsian646-829-9701shamsian@lythampartners.com
Neuraxis (AMEX:NRXS)
Historical Stock Chart
Von Nov 2024 bis Dez 2024
Neuraxis (AMEX:NRXS)
Historical Stock Chart
Von Dez 2023 bis Dez 2024